COPD: Do imaging measurements of emphysema and airway disease explain symptoms and exercise capacity?1

Radiology

Volumn 277, Issue 3, 2015, Pages 872-880

  Kirby, Miranda ^a   Pike, Damien ^b,c   Sin, Don D ^a   Coxson, Harvey O ^a   McCormack, David G ^d   Parraga, Grace ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c Department of Medical Biophysics ^*  (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HELIUM 3; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DISEASE SEVERITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; IMAGE ANALYSIS; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RESIDUAL VOLUME; RESPIRATORY TRACT DISEASE ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOTAL LUNG CAPACITY; EMPHYSEMA; LUNG FUNCTION TEST; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; STATISTICAL ANALYSIS; VERY ELDERLY; WALKER;

AGED; AGED, 80 AND OVER; DATA INTERPRETATION, STATISTICAL; EMPHYSEMA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; WALKERS;

EID: 84948807948     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015150037     Document Type: Article

References (47)

1. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365(13):1184-1192.
2. Coxson HO, Leipsic J, Parraga G, Sin DD. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 2014;190(2): 135-144.
3. Maleki-Yazdi MR, Lewczuk CK, Haddon JM, Choudry N, Ryan N. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study. COPD 2007;4(4):313-320.
4. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009;33(2):262-272.
5. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177(7):743-751.
6. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Am J Respir Crit Care Med 2000;162(3 Pt 1):1102-1108.
7. Mathew L, Kirby M, Etemad-Rezai R, Wheatley A, McCormack DG, Parraga G. Hyperpolarized He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011;79(1):140-146.
8. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7(1):32-43.
9. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008;31(4):869-873.
10. Kim WJ, Hoffman E, Reilly J, et al. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J 2011; 37(1):39-43.
11. Zhou JJ, Cho MH, Castaldi PJ, Hersh CP, Silverman EK, Laird NM. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. Am J Respir Crit Care Med 2013;188(8):941-947.
12. Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology 2011; 261(1):274-282.
13. Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 2013;1(2):129-136.
14. Miller RR, Müller NL, Vedal S, Morrison NJ, Staples CA. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989;139(4):980-983.
15. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005;171(2):142-146.
16. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567-1575.
17. Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med 2010;181(4):353-359.
18. Martinez CH, Chen YH, Westgate PM, et al. Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax 2012; 67(5):399-406.
19. Diaz AA, Bartholmai B, San José Estépar R, et al. Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD. Respir Med 2010;104(8):1145-1151.
20. Gietema HA, Edwards LD, Coxson HO, Bakke PS; ECLIPSE Investigators. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. Respir Med 2013;107(8):1201-1209.
21. Kirby M, Owrangi A, Svenningsen S, et al. On the role of abnormal DL(CO) in exsmokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax 2013;68(8):752-759.
22. Kirby M, Pike D, McCormack DG, et al. Longitudinal computed tomography and magnetic resonance imaging of COPD: Thoracic Imaging Network of Canada (TINCan) study objectives. J COPD Found 2014;1(2):200-211.
23. Global Initiative for Chronic Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www. goldcopd. org/. Published 2013. Accessed May 6, 2014.
24. Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 2011;184(1): 57-63.
25. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
26. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321-1327.
27. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
28. Parraga G, Ouriadov A, Evans A, et al. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3. 0 Tesla. Invest Radiol 2007;42(6): 384-391.
29. Christner JA, Braun NN, Jacobsen MC, Carter RE, Kofler JM, McCollough CH. Sizespecific dose estimates for adult patients at CT of the torso. Radiology 2012;265(3):841-847.
30. Kirby M, Heydarian M, Svenningsen S, et al. Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012;19(2):141-152.
31. Kirby M, Heydarian M, Wheatley A, Mc-Cormack DG, Parraga G. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol (1985) 2012;112(4): 651-657.
32. Van Bell G, Fisher L, Heagerty P, Lumley T. Multiple comparisons in biostatistics: a methodology for the health sciences. 2nd ed. Seattle, Wash: Wiley-Interscience, 2004.
33. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2(1):75-79.
34. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91(2):221-225.
35. O'Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant 2007;41(5):673-690.
36. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177(6):622-629.
37. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(5): 770-777.
38. Kirby M, Pike D, Coxson HO, McCormack DG, Parraga G. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology 2014; 273(3):887-896.
39. van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009;34(6):1311-1321.
40. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to neversmokers. J Magn Reson Imaging 2005;21(4): 365-369.
41. Svenningsen S, Kirby M, Starr D, et al. What are ventilation defects in asthma? Thorax 2014;69(1):63-71.
42. Sukstanskii AL, Quirk JD, Yablonskiy DA. Probing lung microstructure with hyperpolarized 3He gradient echo MRI. NMR Biomed 2014;27(12):1451-1460.
43. Yablonskiy DA, Sukstanskii AL, Leawoods JC, et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci U S A 2002;99(5):3111-3116.
44. Mugler JP 3rd, Altes TA. Hyperpolarized 129Xe MRI of the human lung. J Magn Reson Imaging 2013;37(2):313-331.
45. Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 2010;107(16): 7485-7490.
46. Guan Y, Xia Y, Fan L, et al. Quantitative assessment of pulmonary perfusion using dynamic contrast-enhanced CT in patients with chronic obstructive pulmonary disease: correlations with pulmonary function test and CT volumetric parameters. Acta Radiol 2015;56(5):573-580.
47. Lee CW, Seo JB, Lee Y, et al. A pilot trial on pulmonary emphysema quantification and perfusion mapping in a single-step using contrast-enhanced dual-energy computed tomography. Invest Radiol 2012;47(1):92-97.